Alkermes plc. (ALKS) has 9 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 7 sales totalling $2.3M. Most recent filing: Sept. 3, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 3, 2026 | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | −$97,652 | 2,034 | −1% | Yes | |
|
|
||||||
| Sept. 1, 2026 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | −$187,944 | 19,000 | −6% | Yes | |
|
|
||||||
| Aug. 17, 2026 | Nichols Christian Todd SVP, Chief Commercial Officer | −$372,937 | 7,576 | −7% | Yes | |
|
|
||||||
| Aug. 7, 2026 filed Aug. 5, 2026 | Jackson Blair Curtis President & CEO, Alkermes plc | $0 | 217,534 | 0% | No | |
|
|
||||||
| Aug. 3, 2026 | snyderman nancy lynn MD Director | $161,344 | 133,416 | — | No | |
|
|
||||||
Showing the 5 most recent of 9 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free